What are essential dimensions of personalized medicine which should be considered in policy making A comparative study

Implementation of personalized medicine without considering its challenges in different aspects will be resulted in imposing a lot of expenses to the health system and patients. Therefore, policymakers should investigate implementation of this approach from multiple aspects. This study present essential steps in investigating, promoting and legislation for transforming and adjusting personalized medicine in Iranian’s context, considering institutions and different country’s frameworks. This study is a comparative study between different frameworks of policymaking in personalized medicine. we detect 16 dimension that we should be considered in policy making for personalized medicine including: Creating required legislative authority, Guidelines for assessment and approval of PM medication, Educating healthcare providers, Developing ICT, Compliance with ethical issues, Create conditions for conducting research (such as HTA), Clinical and Analytical Validation of Biomarkers, Patients privacy and Personal Data Protection, Valuation of personalized medicine services, Developing and financing of required researches, Creating bio banks, Creating personalized medicine coalition, Creating new reimbursement mechanisms, Informing and participation of patients, Creating an integrated Patient centres approach, Providing required diagnostic equipment. in order to implementing personalized medicine in Iran we need to an integrated health system an creating changes in different aspects of it, trough coordination between institutions and organizations to informing and Create acceptance in society .So, it seeming that implementation of this strategy in Iran is time-consuming process and need to cooperating between different sectors. Implementation of personalized medicine only by relying on existing knowledge in country can cause a lot of harm to the health system and patients from financial, moral and legal issues.

کلیدواژه ها:

Personalized Medicine ، Policy making ، Comparative study